r-Hu Coagulation Factor VII, also known as recombinant human coagulation factor VIIa (rFVIIa), is a medication that plays a crucial role in blood clotting [1, 2]. Here's a detailed breakdown:
Function:
- Acts like a natural blood clotting factor called factor VII, but is produced in a lab using genetic engineering [1, 3].
- Factor VIIa is a key component of the extrinsic pathway in the blood clotting cascade, which helps form blood clots to stop bleeding [2, 4].
Uses:
- Primarily used to treat or prevent bleeding episodes in people with certain conditions that impair normal clotting:
- Hemophilia A or B with inhibitors: These are rare conditions where the body develops antibodies against clotting factors, rendering them ineffective. rFVIIa works by bypassing the need for these inhibited factors [2, 5].
- Congenital factor VII deficiency: This is a rare inherited disorder where the body doesn't produce enough factor VII [2].
- Acquired hemophilia: This is a temporary condition where blood clotting is impaired due to factors like severe liver disease, trauma, or certain medications [2].
- May also be used off-label for bleeding complications in certain surgeries or severe uncontrolled bleeding situations [2].
How it's administered:
- Given as an injection directly into a vein [1].
Important considerations:
- r-Hu Coagulation Factor VII should only be used under the supervision of a doctor with expertise in bleeding disorders [1].
- Misuse of this medication can increase the risk of blood clots, which can be life-threatening [2].
- Potential side effects include allergic reactions, fever, and headache [1].